Advertisement

Dietary, Complementary and Alternative Therapies

  • Susan L. Hyman
  • Susan E. Levy
Chapter

Abstract

Few treatments for autism generate as much controversy and consternation among families and caregivers than the group of treatments considered as complementary and alternative medical (CAM) treatments. Evidence-based practice should guide all treatments used for symptoms of autism, including behavioral, educational, medical biologic or complementary therapies. All interventions should be held to the same standards of evidence. This chapter discusses commonly used CAM therapies, reports the prevalence for use in children, reviews the factors promoting its use, and discusses the evidence-based evaluation of efficacy of treatments.

Keywords

Cerebral Palsy Down Syndrome Juvenile Rheumatoid Arthritis Music Therapy Hyperbaric Oxygen Therapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Abbreviations

ADHD

Attention deficit hyperactivity disorder

ASDs

Autism spectrum disorders

CAM

Complementary and alternative medical treatments

CGI

Clinical global improvement

DAN

Defeat Autism Now

GFCF

Gluten-free casein-free

HBOT

Hyperbaric oxygen therapy

NCCAM

National Center for Complementary and Alternative Medicine

NIH

National Institutes of Health

RCT

Randomized control trial

References

  1. AAP Committee on Children with Disabilities. (2001). Counseling families who choose complementary and alternative medicine for their child with chronic illness or disability. American Academy of Pediatrics. Pediatrics, 107(3), 598–601.Google Scholar
  2. Adams, J. B., & Holloway, C. (2004). Pilot study of a moderate dose multivitamin/mineral supplement for children with autistic spectrum disorder. Journal of Alternative and Complementary Medicine, 10(6), 1033–1039.CrossRefGoogle Scholar
  3. Adams, J. B., Romdalvik, J., Ramanujam, V. M., & Legator, M. S. (2007). Mercury, lead, and zinc in baby teeth of children with autism versus controls. Journal of Toxicology and Environmental Health, Part A: Current Issues, 70(12), 1046–1051.CrossRefGoogle Scholar
  4. Amminger, G. P., Berger, G. E., Schafer, M. R., Klier, C., Friedrich, M. H., & Feucht, M. (2007). Omega-3 fatty acids supplementation in children with autism: A double-blind randomized, placebo-controlled pilot study. Biological Psychiatry, 61(4), 551–553.PubMedCrossRefGoogle Scholar
  5. Andersen, I. M., Kaczmarska, J., McGrew, S. G., & Malow, B. A. (2008). Melatonin for insomnia in children with autism spectrum disorders. Journal of Child Neurology, 23(5), 482–485.PubMedCrossRefGoogle Scholar
  6. Autism Research Institute (2005) Autism Treatment Evaluation Checklist (ATEC) Report. Retrieved from http://www.autism.com/ind_atec_report.asp.
  7. Bakkaloglu, B., Anlar, B., Anlar, F. Y., Oktem, F., Pehlivanturk, B., et al. (2008). Atopic features in early childhood autism. European Journal of Paediatric Neurology, 12, 476–479.PubMedCrossRefGoogle Scholar
  8. Barnes, P. M., Powell-Griner, E., McFann, K., and Nahin, R. L. (2004) Complementary and alternative medicine use among adults: United States, 2002: Advance data from vital and health statistics. Retrieved from http://www.nccam.nih.gov.
  9. Baron, J. H. (2009). Sailors’ scurvy before and after James Lind: a reassessment. Nutrition Reviews, 67(6), 315–332.PubMedCrossRefGoogle Scholar
  10. Bolman, W. M., & Richmond, J. A. (1999). A double-blind, placebo-controlled, crossover pilot trial of low dose dimethylglycine in patients with autistic disorder. Journal of Autism and Developmental Disorders, 29(3), 191–194.PubMedCrossRefGoogle Scholar
  11. Brown, K. A., & Patel, D. R. (2005). Complementary and alternative medicine in developmental disabilities. Indian Journal of Pediatrics, 72(11), 949–952.PubMedCrossRefGoogle Scholar
  12. Brudnak, M. A., Rimland, B., Kerry, R. E., Dailey, M., Taylor, R., et al. (2002). Enzyme-based therapy for autism spectrum disorders: Is it worth another look? Medical Hypotheses, 58(5), 422–428.PubMedCrossRefGoogle Scholar
  13. Cass, H., Gringras, P., March, J., McKendrick, I., ÓHare, A. E., et al. (2008). Absence of urinary opioid peptides in children with autism. Archives of Disease in Childhood, 93, 745–750.PubMedCrossRefGoogle Scholar
  14. Chez, M. G., Buchanan, C. P., Aimonovitch, M. C., Becker, M., Schaefer, K., et al. (2002). Double-blind, placebo-controlled study of L-carnosine supplementation in children with autistic spectrum disorders. Journal of Child Neurology, 17(11), 833–837.PubMedCrossRefGoogle Scholar
  15. Christison, G. W., & Ivany, K. (2006). Elimination diets in autism spectrum disorders: Any wheat amidst the chaff? Journal of Developmental and Behavioral Pediatrics, 27(2 Suppl), S162–171.PubMedCrossRefGoogle Scholar
  16. Cincotta, D. R., Crawford, N. W., Lim, A., Cranswick, N. E., Skull, S., et al. (2006). Comparison of complementary and alternative medicine use: Reasons and motivations between two tertiary children’s hospitals. Archives of Disease in Childhood, 91(2), 153–158.PubMedCrossRefGoogle Scholar
  17. Cullen, L., & Barlow, J. (2002). ‘Kiss, cuddle, squeeze’: The experiences and meaning of touch among parents of children with autism attending a touch therapy programme. Journal of Child Health Care, 6(3), 171–181.PubMedCrossRefGoogle Scholar
  18. Cullen, L. A., Barlow, J. H., & Cushway, D. (2005). Positive touch, the implications for parents and their children with autism: An exploratory study. Complementary Therapies in Clinical Practice, 11(3), 182–189.PubMedCrossRefGoogle Scholar
  19. Daniel, P. K., & Robert, Z. (2007). Self-hypnosis training for headaches in children and adolescents. Journal of Pediatrics, 150(6), 635–639.CrossRefGoogle Scholar
  20. Danielsson, S., Viggedal, G., Gillberg, C., & Olsson, I. (2008). Lack of effects of vagus nerve stimulation on drug-resistant epilepsy in eight pediatric patients with autism spectrum disorders: A prospective 2-year follow-up study. Epilepsy and Behavior, 12(2), 298–304.PubMedCrossRefGoogle Scholar
  21. Dannemann, K., Hecker, W., Haberland, H., Herbst, A., Galler, A., et al. (2008). Use of complementary and alternative medicine in children with type 1 diabetes mellitus: Prevalence, patterns of use, and costs. Pediatric Diabetes, 9(3 Pt 1), 228–235.PubMedCrossRefGoogle Scholar
  22. Davis, M. P., & Darden, P. M. (2003). Use of complementary and alternative medicine by children in the United States. Archives of Pediatric and Adolescent Medicine, 157(4), 393–396.CrossRefGoogle Scholar
  23. DelGiudice-Asch, G., Simon, L., Schmeidler, J., Cunningham-Rundles, C., & Hollander, E. (1999). Brief report: A pilot open clinical trial of intravenous immunoglobulin in childhood autism. Journal of Autism and Developmental Disorders, 29(2), 157–160.PubMedCrossRefGoogle Scholar
  24. Dolske, M. C., Spollen, J., McKay, S., Lancashire, E., & Tolbert, L. (1993). A preliminary trial of ascorbic acid as supplemental therapy for autism. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 17, 765–774.PubMedCrossRefGoogle Scholar
  25. Downey, P. A., Barbano, T., Kapur-Wadhwa, R., Sciote, J. J., Siegel, M. I., & Mooney, M. P. (2006). Craniosacral therapy: The effects of cranial manipulation on intracranial pressure and cranial bone movement. Journal of Orthopaedic and Sports Physical Therapy, 36(11), 845–853.PubMedCrossRefGoogle Scholar
  26. Elder, J. H., Shankar, M., Shuster, J., Theriaque, D., Burns, S., & Sherrill, L. (2006). The gluten-free, casein-free diet in autism: Results of a preliminary double blind clinical trial. Journal of Autism and Developmental Disorders, 36(3), 413–420.PubMedCrossRefGoogle Scholar
  27. Ernst, E. (1999). Prevalence of complementary/alternative medicine for children: A systematic review. European Journal of Pediatrics, 158(1), 7–11.PubMedCrossRefGoogle Scholar
  28. Escalona, A., Field, T., Singer-Strunck, R., Cullen, C., & Hartshorn, K. (2001). Brief report: Improvements in the behavior of children with autism following massage therapy. Journal of Autism and Developmental Disorders, 31(5), 513–516.PubMedCrossRefGoogle Scholar
  29. Esch, B. E., & Carr, J. E. (2004). Secretin as a treatment for autism: A review of the evidence. Journal of Autism and Developmental Disorders, 34(5), 543–556.PubMedCrossRefGoogle Scholar
  30. Field, T., & Diego, M. (2008). Vagal activity, early growth and emotional development. Infant Behavior and Development, 31, 361–373.PubMedCrossRefGoogle Scholar
  31. Findling, R. L., Maxwell, K., Scotese-Wojtila, L., Huang, J., Yamashita, T., & Wiznitzer, M. (1997). High-dose pyridoxine and magnesium administration in children with autistic disorder: An absence of salutary effects in a double-blind, placebo-controlled study. Journal of Autism and Developmental Disorders, 27(4), 467–478.PubMedCrossRefGoogle Scholar
  32. Fombonne, E. (2008). Thimerosal disappears but autism remains. Archives of General Psychiatry, 65(1), 15–16.PubMedCrossRefGoogle Scholar
  33. Garstang, J., & Wallis, M. (2006). Randomized controlled trial of melatonin for children with autistic spectrum disorders and sleep problems. Child: Care, Health and Development, 32(5), 585–589.CrossRefGoogle Scholar
  34. Geier, D. A., & Geier, M. R. (2006). A clinical trial of combined anti-androgen and anti-heavy metal therapy in autistic disorders. Neuroendocrinology Letters, 27(6), 833–838.PubMedGoogle Scholar
  35. Geier, D. A., & Geier, M. R. (2007a). A case series of children with apparent mercury toxic encephalopathies manifesting with clinical symptoms of regressive autistic disorders. Journal of Toxicology and Environmental Health, Part A: Current Issues, 70(10), 837–851.CrossRefGoogle Scholar
  36. Geier, D. A., & Geier, M. R. (2007b). A prospective study of mercury toxicity biomarkers in autistic spectrum disorders. Journal of Toxicology and Environmental Health, Part A: Current Issues, 70(20), 1723–1730.CrossRefGoogle Scholar
  37. Giannotti, F., Cortesi, F., Cerquiglini, A., & Bernabei, P. (2006). An open-label study of controlled-release melatonin in treatment of sleep disorders in children with autism. Journal of Autism and Developmental Disorders, 36(6), 741–752.PubMedCrossRefGoogle Scholar
  38. Gold, C., Wigram, T., and Elefant, C. (2006) Music therapy for autistic spectrum disorder. Cochrane Database of Systematic Reviews, 2:CD004381.Google Scholar
  39. Golnik, A. E., & Ireland, M. (2009). Complementary alternative medicine for children with autism: A physician survey. Journal of Autism and Developmental Disorders, 39(7), 996–1005.PubMedCrossRefGoogle Scholar
  40. Granpeesheh, D., Bradstreet, J. J., Tarbox, J., Dixon, D. R., Allen, S., & Wilke, A. E. (2009) Randomized placebo-controlled trial of hyperbaric oxygen therapy. Paper presented at the IMFAR, Chicago, IL.Google Scholar
  41. Green, V. A., Pituch, K. A., Itchon, J., Choi, A. O., Reilly, M., Sigafoos, J., (2006). Internet survey of treatments used by parents of children with autism. Res Dev Disabil. 27(1):70-84Google Scholar
  42. Gupta, S., Aggarwal, S., & Heads, C. (1996). Dysregulated immune system in children with autism: Beneficial effects of intravenous immune globulin on autistic characteristics. Journal of Autism and Developmental Disorders, 26(4), 439–452.PubMedCrossRefGoogle Scholar
  43. Handen, B. L., Melmed, R. D., Hansen, R. L., Aman, M. G., Burnham, D. L., et al. (2009). A double-blind, placebo-controlled trial of oral human immunoglobulin for gastrointestinal dysfunction in children with autistic disorder. Journal of Autism and Developmental Disorders, 39(5), 796–805.PubMedCrossRefGoogle Scholar
  44. Hanson, E., Kalish, L. A., Bunce, E., Curtis, C., McDaniel, S., et al. (2007). Use of complementary and alternative medicine among children diagnosed with autism spectrum disorder. Journal of Autism and Developmental Disorders, 37(4), 628–636.PubMedCrossRefGoogle Scholar
  45. Heuer, L., Ashwood, P., Schauer, J., Krakowiak, P., Hertz-Picciotto, I., et al. (2008). Reduced levels of immunoglobulin in children with autism correlates with behavioral symptoms. Autism Research, 1(5), 275–183.PubMedCrossRefGoogle Scholar
  46. Hyland, M. E. (2003). Methodology for the scientific evaluation of complementary and alternative medicine. Complementary Therapies in Medicine, 11(3), 146–153.PubMedCrossRefGoogle Scholar
  47. James, S. J., Cutler, P., Melnyk, S., Jernigan, S., Janak, L., et al. (2004). Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. American Journal of Clinical Nutrition, 80(6), 1611–1617.PubMedGoogle Scholar
  48. James, S. J., Melnyk, S., Fuchs, G., Reid, T., Jernigan, S., et al. (2009). Efficacy of methylcobalamin and folinic acid treatment on glutathione redox status in children with autism. American Journal of Clinical Nutrition, 89(1), 425–430.PubMedCrossRefGoogle Scholar
  49. Jensen, P. S., & Kenny, D. T. (2004). The effects of yoga on the attention and behavior of boys with attention-deficit/hyperactivity disorder (ADHD). Journal of Attention Disorders, 7(4), 205–216.PubMedCrossRefGoogle Scholar
  50. Jyonouchi, H. (2009). Food allergy and autism spectrum disorders: Is there a link? Current Allergy and Asthma Reports, 9(3), 194–201.PubMedCrossRefGoogle Scholar
  51. Kazdin, A. E. (2004). Evidence-based treatments: Challenges and priorities for practice and research. Child and Adolescent Psychiatric Clinics of North America, 13(4), 923–940.PubMedCrossRefGoogle Scholar
  52. Kelly, K. M. (2007). Complementary and alternative medicines for use in supportive care in pediatric cancer. Support Care Cancer, 15(4), 457–460.PubMedCrossRefGoogle Scholar
  53. Kemper, K. J., Vohra, S., Walls, R., & the Task Force on Complementary and Alternative Medicine, and the Provisional Section on Complementary, Holistic, and Integrative Medicine. (2008). The use of complementary and alternative medicine in pediatrics. Pediatrics, 122(6), 1374–1386.PubMedCrossRefGoogle Scholar
  54. Kern, J. K., Miller, V. S., Cauller, L., Kendall, R., Mehta, J., & Dodd, M. (2001). Effectiveness of N, N-Dimethylglycine in autism and pervasive developmental disorder. Journal of Child Neurology, 16(3), 169–173.PubMedGoogle Scholar
  55. Knivsberg, A. M., Reichelt, K. L., Hoien, T., & Nodland, M. (2002). A randomised, controlled study of dietary intervention in autistic syndromes. Nutritional Neuroscience, 5(4), 251–261.PubMedCrossRefGoogle Scholar
  56. Kuriyama, S., Kamiyama, M., Watanabe, M., Tamabashi, S., Muraguchi, I., et al. (2002). Pyridoxine treatment in a subgroup of children with pervasive developmental disorders. Developmental Medicine and Child Neurology, 44(4), 283–286.CrossRefGoogle Scholar
  57. Levy, S., & Hyman, S. (2005). Novel treatments for autistic spectrum disorders. Mental Retardation and Developmental Disabilities Research Reviews, 11, 131–142.PubMedCrossRefGoogle Scholar
  58. Levy, S. E., Mandell, D. S., Merhar, S., Ittenbach, R. F., & Pinto-Martin, J. A. (2003). Use of complementary and alternative medicine among children recently diagnosed with autistic spectrum disorder. Journal of Developmental and Behavioral Pediatrics, 24(6), 418–423.PubMedCrossRefGoogle Scholar
  59. Liptak, G. S. (2005). Complementary and alternative therapies for cerebral palsy. Mental Retardation and Developmental Disabilities Research Reviews, 11(2), 156–163.PubMedCrossRefGoogle Scholar
  60. Martineau, J., Barthelemy, C., Garreau, B., & Lelord, G. (1985). Vitamin B6:magnesium and combined B6-Mg: Therapeutic effects in childhood autism. Biological Psychiatry, 20(5), 467–478.PubMedCrossRefGoogle Scholar
  61. McCann, D., Barrett, A., Cooper, A., Crumpler, D., Dalen, L., et al. (2007). Food additives and hyperactive behaviour in 3-year-old and 8/9-year-old children in the community: A randomised, double-blinded, placebo-controlled trial. Lancet, 370(9598), 1560–1567.PubMedCrossRefGoogle Scholar
  62. Millward, C., Ferriter, M., Calver, S., & Connell-Jones, G. (2008) Gluten- and casein-free diets for autistic spectrum disorder. Cochrane Database of Systematic Reviews, 2:CD003498.Google Scholar
  63. Mitka, M. (2008). Chelation therapy trials halted. Journal of the American Medical Association, 300(19), 2236.PubMedCrossRefGoogle Scholar
  64. Moretti, P., Sahoo, T., Hyland, K., Bottiglieri, T., Peters, S., et al. (2005). Cerebral folate deficiency with developmental delay, autism, and response to folinic acid. Neurology, 64(6), 1088–1090.PubMedGoogle Scholar
  65. Mousain-Bosc, M., Roche, M., Polge, A., Pradal-Prat, D., Rapin, J., & Bali, J. P. (2006). Improvement of neurobehavioral disorders in children supplemented with magnesium-vitamin B6: II. Pervasive developmental disorder – autism. Magnesium Research, 19(1), 53–62.PubMedGoogle Scholar
  66. Ng, D. K., Chan, C. H., Soo, M. T., & Lee, R. S. (2007). Low-level chronic mercury exposure in children and adolescents: Meta-analysis. Pediatrics International, 49(1), 80–87.PubMedCrossRefGoogle Scholar
  67. Niehus, R., & Lord, C. (2006). Early medical history of children with autism spectrum disorders. Journal of Developmental and Behavioral Pediatrics, 27(2 Suppl), S120–127.PubMedCrossRefGoogle Scholar
  68. Nye, C., & Brice, A. (2005) Combined vitamin B6-magnesium treatment in autism spectrum disorder. Cochrane Database of Systematic Reviews, 4:CD003497.Google Scholar
  69. Park, Y. D. (2003). The effects of vagus nerve stimulation therapy on patients with intractable seizures and either Landau-Kleffner syndrome or autism. Epilepsy and Behavior, 4(3), 286–290.PubMedCrossRefGoogle Scholar
  70. Patel, K., & Curtis, L. T. (2007). A comprehensive approach to treating autism and attention-deficit hyperactivity disorder: A prepilot study. Journal of Alternative and Complementary Medicine, 13(10), 1091–1097.CrossRefGoogle Scholar
  71. Plioplys, A. V. (1998). Intravenous immunoglobulin treatment of children with autism. Journal of Child Neurology, 13(2), 79–82.PubMedCrossRefGoogle Scholar
  72. Rhee, S. M., Garg, V. K., & Hershey, C. O. (2004). Use of complementary and alternative medicines by ambulatory patients. Archives of Internal Medicine, 164(9), 1004–1009.PubMedCrossRefGoogle Scholar
  73. Roizen, N. J. (2005). Complementary and alternative therapies for Down syndrome. Mental Retardation and Developmental Disabilities Research Reviews, 11(2), 149–155.PubMedCrossRefGoogle Scholar
  74. Rossignol, D. A., Rossignol, L. W., James, S. J., Melnyk, S., & Mumper, E. (2007). The effects of hyperbaric oxygen therapy on oxidative stress, inflammation, and symptoms in children with autism: An open-label pilot study. BMC Pediatrics, 7(1), 36.PubMedCrossRefGoogle Scholar
  75. Rossignol, D. A., Rossignol, L. W., Smith, S., Schneider, C., Logerquist, S., et al. (2009). Hyperbaric treatment for children with autism: A multicenter, randomized, double-blind, controlled trial. BMC Pediatrics, 9, 21.PubMedCrossRefGoogle Scholar
  76. Rouster-Stevens, K., Nageswaran, S., Arcury, T. A., & Kemper, K. J. (2008). How do parents of children with juvenile idiopathic arthritis ( JIA) perceive their therapies? BMC Complementary and Alternative Medicine, 8, 25.PubMedCrossRefGoogle Scholar
  77. Sandler, A. D., & Bodfish, J. W. (2000). Placebo effects in autism: Lessons from secretin. Journal of Developmental and Behavioral Pediatrics, 21(5), 347–350.PubMedCrossRefGoogle Scholar
  78. Sandler, R. H., Finegold, S. M., Bolte, E. R., Buchanan, C. P., Maxwell, A. P., et al. (2000). Short-term benefit from oral vancomycin treatment of regressive-onset autism. Journal of Child Neurology, 15(7), 429–435.PubMedCrossRefGoogle Scholar
  79. Schechter, R., & Grether, J. K. (2008). Continuing increases in autism reported to California’s developmental services system: Mercury in retrograde. Archives of General Psychiatry, 65(1), 19–24.PubMedCrossRefGoogle Scholar
  80. Schneider, C. K., Melmed, R. D., Barstow, L. E., Enriquez, F. J., Ranger-Moore, J., & Ostrem, J. A. (2006). Oral human immunoglobulin for children with autism and gastrointestinal dysfunction: A prospective, open-label study. Journal of Autism and Developmental Disorders, 36(8), 1053–1064.PubMedCrossRefGoogle Scholar
  81. Silva, L. M., & Cignolini, A. (2005). A medical Qigong methodology for early intervention in autism spectrum disorder: A case series. American Journal of Chinese Medicine, 33(2), 315–327.PubMedCrossRefGoogle Scholar
  82. Silva, L. M., Cignolini, A., Warren, R., Budden, S., & Skowron-Gooch, A. (2007). Improvement in sensory impairment and social interaction in young children with autism following treatment with an original Qigong massage methodology. American Journal of Chinese Medicine, 35(3), 393–406.PubMedCrossRefGoogle Scholar
  83. Sinha, Y., Silove, N., Wheeler, D., & Williams, K. (2004) Auditory integration training and other sound therapies for autism spectrum disorders. Cochrane Database of Systematic Reviews, 1:CD003681.Google Scholar
  84. Sinha, Y., Silove, N., Wheeler, D., & Williams, K. (2006). Auditory integration training and other sound therapies for autism spectrum disorders: A systematic review. Archives of Disease in Childhood, 91(12), 1018–1022.PubMedCrossRefGoogle Scholar
  85. So, P. S., Jiang, Y., & Qin, Y. (2008) Touch therapies for pain relief in adults. Cochrane Database of Systematic Reviews, 4:CD006535.Google Scholar
  86. Soden, S. E., Lowry, J. A., Garrison, C. B., & Wasserman, G. S. (2007). 24-hour provoked urine excretion test for heavy metals in children with autism and typically developing controls: A pilot study. Clinical Toxicology, 45(5), 476–481.PubMedCrossRefGoogle Scholar
  87. Spigelblatt, L., Laine-Ammara, G., Pless, I. B., & Guyver, A. (1994). The use of alternative medicine by children. Pediatrics, 94(6 Pt 1), 811–814.PubMedGoogle Scholar
  88. Sweeten, T. L., Bowyer, S. L., Posey, D. J., Halberstadt, G. M., & McDougle, C. J. (2003). Increased prevalence of familial autoimmunity in probands with pervasive developmental disorders. Pediatrics, 112(5), e420.PubMedCrossRefGoogle Scholar
  89. Tolbert, L., Haigler, T., Waits, M. M., Dennis, T. (1993) Brief REport: Lack of Response in an autistic population to a low dose clinical trial of pyridoxine and magnesium. Journal of Autism and Developmental Disorders, 23(1): 193-9Google Scholar
  90. Verhoef, M. J., Vanderheyden, L. C., Dryden, T., Mallory, D., & Ware, M. A. (2006). Evaluating complementary and alternative medicine interventions: In search of appropriate patient-centered outcome measures. BMC Complementary and Alternative Medicine, 6, 6–38.PubMedCrossRefGoogle Scholar
  91. Wasdell, M. B., Jan, J. E., Bomben, M. B., Freeman, R. D., Rietveld, W. J., et al. (2008). A randomized, placebo-controlled trial of controlled release melatonin treatment of delayed sleep phase syndrome and impaired sleep maintenance in children with neurodevelopmental disabilities. Journal of Pineal Research, 44(1), 57–64.PubMedGoogle Scholar
  92. Weber, W., & Newmark, S. (2007). Complementary and alternative medical therapies for attention-deficit/hyperactivity disorder and autism. Pediatric Clinics of North America, 54(6), 983–1006.PubMedCrossRefGoogle Scholar
  93. Whipple, J. (2004). Music in intervention for children and adolescents with autism: A meta-analysis. Journal of Music Therapy, 41(2), 90–106.PubMedGoogle Scholar
  94. Whiteley, P., Rodgers, J., Savery, D., & Shattock, P. (1999). A gluten-free diet as an intervention for autism and associated spectrum disorders: Preliminary findings. Autism, 3(1), 45–65.CrossRefGoogle Scholar
  95. Williams, K. W., Wray, J. J., & Wheeler, D. M. (2005) Intravenous secretin for autism spectrum disorder. Cochrane Database of Systematic Reviews, 3:CD003495.Google Scholar
  96. Williams, T. I. (2006). Evaluating effects of aromatherapy massage on sleep in children with autism: A pilot study. Evidence-based Complementary and Alternative Medicine, 3(3), 373–377.PubMedCrossRefGoogle Scholar
  97. Wills, S., Cabanlit, M., Bennett, J., Ashwood, P., Amaral, D., & Van de Water, J. (2007). Autoantibodies in autism spectrum disorders (ASD). Annals of the New York Academy of Sciences, 1107, 79–91.PubMedCrossRefGoogle Scholar
  98. Wilson, K. M., Klein, J. D., Sesselberg, T. S., Yussman, S. M., Markow, D. B., et al. (2006). Use of complementary medicine and dietary supplements among US adolescents. Journal of Adolescent Health, 38(4), 385–394.PubMedCrossRefGoogle Scholar
  99. Wong, H. H., & Smith, R. G. (2006). Patterns of complementary and alternative medical therapy use in children diagnosed with autism spectrum disorders. Journal of Autism and Developmental Disorders, 36(7), 901–909.PubMedCrossRefGoogle Scholar
  100. Zuzak, T. J., Zuzak-Siegrist, I., Simoes-Wust, A. P., Rist, L., & Staubli, G. (2008). Use of complementary and alternative medicine by patients presenting to a paediatric emergency department. European Journal of Pediatrics, 168(4), 431–437.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Golisano Children’s Hospital at StrongUniversity of RochesterRochesterUSA
  2. 2.The Children’s Hospital of PhiladelphiaThe University of PennsylvaniaPhiladelphiaUSA

Personalised recommendations